🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was designed to investigate the 1 year efficacy and safety of th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-06
Trial ID
NCT00929110
Treatments Being Tested
The study purpose is to evaluate the effect of QAB149 * NVA237 vs. QAB149 ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-11
Trial ID
NCT01699685
The purpose of the study is to provide long term safety data of NVA237. Thi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10
Trial ID
NCT01697696
Treatments Being Tested
This study will assess of the efficacy and safety of a once-daily, 50µg inh...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-03
Trial ID
NCT01566604
The purpose of this trial is to characterize the bronchodilator effects and...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-05-04
Trial ID
NCT03137784
Treatments Being Tested
This study will assess the efficacy, safety and tolerability of indacaterol...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-12
Trial ID
NCT01712516
The study serves to determine whether the treatment of patients with stable...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-11
Trial ID
NCT01715298
The purpose of this study is to further figure out differences of glycopyrr...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-08
Trial ID
NCT01922271
Treatments Being Tested
The main goal of this study is to evaluate the efficacy and safety of glyco...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-02-14
Trial ID
NCT01985334
Treatments Being Tested
This study will assess the efficacy, tolerability and safety of NVA237 comp...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-04
Trial ID
NCT01513460
Treatments Being Tested